Vimarsana
Biggest News Aggregation in the World

Page 22 - Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Material Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Material Command Today - Breaking & Trending Today

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook - Vimarsana News

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook

Published: May 3, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomState Of New JerseyNew JerseyBruxelles CapitaleCity OfJiny KimEric KimPhillip ChanBuildout Of The CompanyEuroelso CongressMaterial CommandEuropean UnionUs ArmyBlood InstituteNational HeartCytosorbents CorporationAsklepios GroupInternational SafeUs Department Of HealthHuman ServicesNational Institutes Of HealthUs AirCompany FormInternational Journal Of Artificial Organs
CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany - Vimarsana News

CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany

Published: May 2, 2022

MONMOUTH JUNCTION, N.J., May 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condit...

Source: businessinsider.com
Related Topics:
United StatesChristian SteinerMaterial CommandEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartAsklepios GroupNational Institutes Of HealthHuman ServicesUs Department Of HealthUs AirPrnewswire Cytosorbents CorporationCorporate CommunicationsSorbents CorporationAsklepios KlinikExecutive Vice PresidentUse AuthorizationRemoval SystemTimely Antithrombotic Removal TicagrelorNational InstitutesOperations CommandAir Force Material CommandPrivate Securities Litigation Reform Act
First Patient Enrolled in U.S. STAR-D Pivotal Trial Evaluating the DrugSorb™-ATR Antithrombotic Removal System to Remove Apixaban and Rivaroxaban During Cardiothoracic Surgery - Vimarsana News

First Patient Enrolled in U.S. STAR-D Pivotal Trial Evaluating the DrugSorb™-ATR Antithrombotic Removal System to Remove Apixaban and Rivaroxaban During Cardiothoracic Surgery

Published: April 29, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...

Source: prnewswire.com
Related Topics:
United StatesEfthymiosn DeliargyrisEric KimApixaban EliquisJanssen BayerMaterial CommandEuropean UnionExpenditure PanelUs ArmyBlood InstituteCytosorbents CorporationNational HeartNational Institutes Of HealthHuman ServicesUs Department Of HealthUs AirCorporate CommunicationsAgency For Healthcare ResearchChief Medical OfficerCytosorbents Breakthrough Device DesignationDirect Oral AnticoagulantsSorbents CorporationUse AuthorizationRemoval SystemTimely Antithrombotic Removal Ticagrelor
CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress - Vimarsana News

CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress

Published: April 28, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesJw Awori HayangaKlinikum IbbenbuerenEric KimRoberto Lorusso DeputyPhillip ChanFederico PappalardoVascular InstituteMaterial CommandVirginia University School Of MedicineVascular CentreEuropean UnionUs ArmyCytosorbents CorporationNational HeartBlood InstituteMaastricht University Medical CentreUs Department Of HealthNational Institutes Of HealthHuman ServicesUs AirSemmelweis UniversityCorporate CommunicationsDepartment Of CardioNational Hospital Allesandria
CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress - Vimarsana News

CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress

Published: April 28, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesJw Awori HayangaKlinikum IbbenbuerenEric KimRoberto Lorusso DeputyPhillip ChanFederico PappalardoVascular InstituteMaterial CommandVirginia University School Of MedicineVascular CentreEuropean UnionUs ArmyCytosorbents CorporationNational HeartBlood InstituteMaastricht University Medical CentreUs Department Of HealthNational Institutes Of HealthHuman ServicesUs AirSemmelweis UniversityCorporate CommunicationsDepartment Of CardioNational Hospital Allesandria